Used in the synthesis of anticoagulant drugs, particularly as an intermediate in the production of vitamin K antagonists. It serves as a key chiral building block in pharmaceuticals that inhibit blood clotting. Also employed in research for developing new cardiovascular medications due to its structural similarity to coumarin derivatives. Its cyclic framework and functional groups make it suitable for modifying and optimizing drug candidates targeting thrombosis and related disorders.